Literature DB >> 15671749

Structure-based preliminary analysis of immunity and virulence of SARS coronavirus.

Yan Li1, Chunqing Luo, Wei Li, Zhao Xu, Changqing Zeng, Shenli Bi, Jun Yu, Jun Wu, Huanming Yang.   

Abstract

The research on SARS-associated coronavirus (SARS-CoV) has not stopped since its discovery, but the pathogenesis of SARS is still unclear. To explore the possible molecular mechanisms of the invasion and virulence of SARS-CoV, we investigated the structural basis of the viral proteins using computational biology. Forty-five motifs relating to superantigens, toxins and other bioactive molecules were detected in the proteins of SARS-CoV. The results showed that the distribution of the motifs varied in different proteins. Enzyme-like motifs were located in the R protein, while ICAM- 1-like and toxin-like molecules were located in the spike, envelop, nucleocapsid, PUP1, PUP 2 and PUP 4 proteins. Comparison of SARS-CoV with other viruses (OC43, PEDV, HRSV, HHerpV and HAdenoV) showed that each group of motifs was different for each type of virus. Data suggest that the proteins of SARS-CoV with toxic motifs might play crucial roles in targeting host cells and interfering with the immune system. This study provides new information for drug and vaccine design, as well as therapeutic strategies against SARS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15671749     DOI: 10.1089/vim.2004.17.528

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  11 in total

1.  Human neutralizing Fab molecules against severe acute respiratory syndrome coronavirus generated by phage display.

Authors:  Xiaoping Kang; Bao-An Yang; Yuyang Hu; Hui Zhao; Wei Xiong; Yinhui Yang; Bingyin Si; Qingyu Zhu
Journal:  Clin Vaccine Immunol       Date:  2006-08

2.  Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

Authors:  Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Scott Winslow; Justin Hoopes; Joseph K-K Li; Jongdae Lee; Dennis A Carson; Howard B Cottam; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-03-24       Impact factor: 5.970

3.  Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.

Authors:  Mary Hongying Cheng; She Zhang; Rebecca A Porritt; Magali Noval Rivas; Lisa Paschold; Edith Willscher; Mascha Binder; Moshe Arditi; Ivet Bahar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-28       Impact factor: 11.205

4.  Cardiac involvement in a child post COVID-19: a case from Lebanon.

Authors:  Tania H Abi Nassif; Karim N Daou; Theresia Tannoury; Marianne Majdalani
Journal:  BMJ Case Rep       Date:  2021-06-29

Review 5.  SARS-CoV-2: A Piece of Bad News.

Authors:  Shatha F Abdullah; Inas K Sharquie
Journal:  Medeni Med J       Date:  2020-06-30

6.  An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations.

Authors:  Mary Hongying Cheng; She Zhang; Rebecca A Porritt; Moshe Arditi; Ivet Bahar
Journal:  bioRxiv       Date:  2020-05-21

7.  Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response.

Authors:  Yan Li; Ming Chen; Hongwei Cao; Yuanfeng Zhu; Jiang Zheng; Hong Zhou
Journal:  Microbes Infect       Date:  2012-10-30       Impact factor: 2.700

8.  Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells.

Authors:  Fabrizio Poccia; Chiara Agrati; Concetta Castilletti; Licia Bordi; Cristiana Gioia; Douglas Horejsh; Giuseppe Ippolito; Paul K S Chan; David S C Hui; Joseph J Y Sung; Maria Rosaria Capobianchi; Miroslav Malkovsky
Journal:  J Infect Dis       Date:  2006-03-27       Impact factor: 5.226

9.  SARS attacks!

Authors:  Sophia Häfner
Journal:  Microbes Infect       Date:  2012-12-20       Impact factor: 2.700

Review 10.  Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

Authors:  Tommy R Tong
Journal:  Perspect Med Virol       Date:  2006-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.